Annotation Detail

Information
Associated Genes
CDKN2A
Associated Variants
CDKN2A p16 EXPRESSION
CDKN2A p16 EXPRESSION
Associated Disease
head and neck squamous cell carcinoma
Source Database
CIViC Evidence
Description
Patients from three studies (RTOG 0129, 0234, and 0522; 85, 95 and 142 patients, respectively) were retrospectively analyzed for p16 (CDKN2A) expression (IHC) and HPV-high risk status (ISH). p16 expression in non-oropharyngeal HNSSC was also prognostic and associated with a better outcome. However, p16-positive oropharyngeal HNSSC still had better PFS and OS than p16-positive non-oropharyngeal HNSSC.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/804
Gene URL
https://civic.genome.wustl.edu/links/genes/14
Variant URL
https://civic.genome.wustl.edu/links/variants/272
Rating
3
Evidence Type
Prognostic
Disease
Head And Neck Squamous Cell Carcinoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Better Outcome
Pubmed
25267748
Drugs